A meta-analysis of 21 studies and almost 3000 ovarian cancer patients confirmed that high levels of intra-epithelial CD3+ or CD8+ T cells were most significantly associated with both improved progression-free and overall survival [185]. This evidence concerns the gene CD8A and ovarian carcinoma.